Klara Dickinson-Eason
2014
In 2014, Klara Dickinson-Eason earned a total compensation of $180.8K as SVP, Chief Regulatory Office at Anthera Pharmaceuticals.
Compensation breakdown
| Option Awards | $180,795 |
|---|---|
| Total | $180,795 |
Dickinson-Eason received $180.8K in option awards, accounting for 100% of the total pay in 2014.
Rankings
In 2014, Klara Dickinson-Eason's compensation ranked 12,562nd out of 13,032 executives tracked by ExecPay. In other words, Dickinson-Eason earned more than 3.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,562 out of 13,032 | 4th |
Division Manufacturing | 4,795 out of 4,965 | 3rd |
Major group Chemicals And Allied Products | 1,644 out of 1,690 | 3rd |
Industry group Drugs | 1,331 out of 1,369 | 3rd |
Industry Pharmaceutical Preparations | 1,018 out of 1,042 | 2nd |
Source: SEC filing on March 16, 2017.
Dickinson-Eason's colleagues
We found six more compensation records of executives who worked with Klara Dickinson-Eason at Anthera Pharmaceuticals in 2014.
2014
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2014
Colin Hislop
Anthera Pharmaceuticals
Chief Medical Officer
2014
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2014
May Liu
Anthera Pharmaceuticals
SVP, Finance & Administration
2014
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2014
Klara Dickinson
Anthera Pharmaceuticals